| Financial Year |
March 31 2023 |
| Monetary Funds |
2,168,169,353.34 |
| Held-for-trading Financial Assets |
413,852.95 |
| Notes Receivable |
40,880,546.34 |
| Accounts Receivable |
733,603,645.09 |
| Advances to Suppliers |
1,180,930,575.22 |
| Other Receivables |
232,604,780.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,040,000.00 |
| Inventories |
1,422,229,794.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,776,279.51 |
| Other Current Assets |
172,229,324.92 |
| Total Current Assets |
6,014,653,126.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,270,351.70 |
| Long-term Equity Investment |
394,319,990.87 |
| Investment Properties |
543,731,500.31 |
| Fixed Assetes |
9,531,029,811.71 |
| Under-construction Projects |
1,425,842,624.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
462,812,627.59 |
| R&D expenses |
-- |
| Goodwill |
317,267,570.09 |
| Long-Term Deferred and Prepaid Expenses |
35,689,805.33 |
| Deferred Income Tax Assets |
278,072,681.23 |
| Other Non-Current Assets |
210,493,559.24 |
| Sub-Total of Non-Current Assets |
14,929,896,332.08 |
| Total Assets |
20,944,549,458.38 |
| Short-Term Loans |
3,585,318,063.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,436,100,000.00 |
| Accounts Payable |
899,476,527.99 |
| Accounts Received In Advance |
11,793,756.78 |
| Employee Compensation Payable |
25,193,791.83 |
| Taxes Payable |
180,814,836.09 |
| Interest Payable |
81,979,037.63 |
| Dividend Payable |
-- |
| Other payables |
614,630,248.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,361,329,281.81 |
| Other Current Liabilities |
69,373,781.27 |
| Sub-Total of Current Liabilities |
9,519,014,303.68 |
| Long-term Loans |
4,701,458,034.61 |
| Bonds Payable |
499,305,221.42 |
| Long-Term Accounts Payable |
1,206,058,484.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
157,454,204.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,880,256,640.95 |
| Total Liabilities |
16,399,270,944.63 |
| Paid-In Capital(Or Share Stock) |
1,465,710,722.00 |
| Capital Surplus |
762,134,530.29 |
| Surplus Reserve |
245,635,316.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
637,083,373.80 |
| Minority Stockholder's Interest |
1,430,204,472.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,115,074,041.73 |
| Owner's Equity（Stockholder's Equity） |
4,545,278,513.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,944,549,458.38 |
